 |
 Ignore The Naysayers... Buy Chinese Stocks! by Robert Morris, Editor China's making headlines again. And once again, it's for all the wrong reasons. On Friday, China's National Bureau of Statistics reported that industrial production rose just 9.3% year over year in April. That's down from 11.9% growth in March. And the number missed estimates for an increase of 12.2%. The disappointing industrial production data follows the recently reported drop in GDP. -------------Sponsor------------- Currencies are risky and you need a lot of money to invest in them, right? WRONG! Our own in-house currency expert, Karl Stevenson, can show you the secrets to making insane amounts of money from the movement of the world's currencies. And forget about unlimited risk, spending all day in front of a computer, and having tons of money to start with... Karl can show you how to easily and safely take $2,000 and turn it into $75,410 or more... over and over again! Click here to find out how... ------------------------------------ In April, the government said GDP grew at a slower pace in the first quarter than most economists were expecting. What's more, the quarter marked the weakest period of growth in nearly three years. Clearly, the data paint a picture of slowing growth in the world's second largest economy. What's more, the data has further emboldened the China bears. They're all pointing to the recent data as further evidence that Chinese stocks are heading lower from here. But I disagree. The bears are merely sensationalizing the bad news to scare investors out of Chinese stocks. It makes perfect sense. Massive selling of Chinese stocks would provide a big boost to the bears' short positions. What the bears aren't telling you is the Chinese government's ramping up efforts to boost growth. On Saturday, the government lowered the reserve-requirement ratio (RRR) for the third time since November 2011. The RRR was cut by another 0.5 percentage points, bringing it down to 20%. The RRR is used to determine the amount of deposits banks must hold in reserve rather than lend out. By cutting the RRR, the government is freeing up the nation's banks to lend out a lot more money going forward. In fact, Goldman Sachs estimates the move will release $71 billion into China's financial system. But here's the key... Cutting the RRR is not doing enough to stimulate growth in China. The government has cut the rate three times since November, but the economy is still slowing. Clearly, more stimulus is needed. This can mean only one thing. The Chinese government has to take their strategy for loosening monetary policy to the next level. That's right... interest rate cuts. Lowering interest rates is the most direct way to stimulate China's economy. Lower rates provide businesses with an incentive to borrow funds and invest them back into the economy. What's more, rate cuts lower the amount of interest paid on fixed income investments. This provides investors with a huge incentive to move money out of bonds and into assets with higher growth potential... like stocks. And make no mistake, the Chinese government will do whatever is necessary to stimulate growth and boost the country's flagging stock market this year. How can I be so confident China's Communist leadership will take the necessary steps to right the economy? Simple. The government's preparing for a once-in-a-decade transfer of power later this year. And they definitely don't want this delicate process threatened by social unrest over declining economic growth. To ensure this power transfer goes off without a hitch, the government is sure to do everything in its power to get the economy back on track. Bottom line... This is a great time to buy Chinese stocks. With the Shanghai Composite down more than 60% from the 2007 peak, many Chinese stocks are trading at bargain basement levels. But these low valuations won't last forever. The government's loose monetary policy is bound to send Chinese stocks soaring sooner rather than later. Take a closer look at some high-quality Chinese stocks or a Chinese Stock ETF for your own portfolio today. Profitably Yours, Robert Morris | Monday, May 14, 2012  • HJ Heinz (HNZ) hit a new 52-week high of $55.07. The ketchup maker's market cap is now just over $17.5 billion. • Biogen (BIIB) set a new 52-week high of $137.50. The biotech now has a market cap of nearly $33 billion. • Sony (SNE) fell to a new 52-week low of $13.97. The consumer electronics manufacturer has a market cap of just over $14 billion.  "Hell, there are no rules here - we're trying to accomplish something." -Thomas Edison   
 Private Equity Will Make A Killing On Natural Gas... You Can Too Friday, May 11, 2012 The Spread Trader: Bear Put Spread On Morgan Stanley (MS) Wednesday, May 9, 2012 Three Reasons Why I'm Not Buying The Facebook IPO Monday, May 7, 2012    |
 Copyright 2012 Hyperion Financial Group, LLC. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This email may only be used pursuant to the subscription agreement controlling use of the Dynamic Wealth Report website and any reproduction, copying, or redistribution of this email or its contents, in whole or in part, is strictly prohibited without the express written permission of Hyperion Financial Group, LLC. LEGAL DISCLAIMER: Neither Hyperion Financial Group LLC nor any of its employees are a registered investment advisor or a Broker/Dealer. As such, Hyperion Financial Group, LLC does not offer or provide personalized investment advice. Although Hyperion Financial Group, LLC employees may answer general customer service questions, they are not licensed under securities laws to address your particular investment situation. Nothing in this report, nor any communication by our employees to you should be considered personalized investment advice. Owners and writers may have positions in the securities that are discussed. However, no associated employees may intentionally engage in any transaction that directly or indirectly competes with the interests of our subscribers. We accept no compensation from any companies mentioned in our reports. Past performance is no guarantee of future results. All information is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell any security. All opinions, analyses and information contained herein are based on sources believed to be reliable and written in good faith, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. Investments recommended in this publication should only be made after consulting with your financial advisor. Any brokers mentioned herein constitute a partial list of available brokers and is for your information only. We do not recommend or endorse any brokers, dealers, or investment advisors. |
| This message was sent to ignoble.experiment@arconati.us from: Hyperion Financial | 20701 N Scottsdale Rd, Ste 107-154 | Scottsdale, AZ 85255 | Email Marketing by |
| Manage Your Subscription | Forward To a Friend |
No comments:
Post a Comment
Keep a civil tongue.